SYMPHONY-2, A Trial to Examine Combination of Tazemetostat With Rituximab in Subjects With Relapsed/Refractory Follicular Lymphoma

USOR/ NY Oncology Hematology, Albany

USOR/Virginia Cancer Specialists, Gainesville

USOR/Oncology & Hematology Associates of Southwest Virginia, Roanoke

East Carolina University, Greenville

Alabama Oncology, Birmingham

XCancer/Tennessee Cancer Specialists, Knoxville

USOR/ Oncology & Hematology Care Clinical Trials, Cincinnati

XCancer/Dayton Physicians Network, Kettering

Revive/Hematology Oncology Associates of Rockland, Sterling Heights

Revive/Oakland Medical Group, Farmington Hills

XCancer/ Northwest Oncology & Hematology, Rolling Meadows

USOR/ Illinois Cancer Specialists, Niles

USOR/Texas Oncology, Dallas

USOR/ Texas Oncology, Tyler

USOR/ Texas Oncology, San Antonio

USOR/Texas Oncology, Weslaco

USOR/ Texas Oncology, Austin

USOR/Rocky Mountain Cancer Centers, Boulder

Compassionate Cancer Care, Fountain Valley

Swedish Cancer Institute, Seattle